Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2007
11/28/2007CN100350930C External-application Chinese medicine for treating psoriasis
11/28/2007CN100350927C Ointment for scars
11/28/2007CN100350921C Dermatosis eliminating medicine
11/28/2007CN100350920C Chinese medicine calculosis and preparation thereof
11/28/2007CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/28/2007CN100350916C Extraction process of effective component for compound Chinese medicine composition of asiaticoside
11/28/2007CN100350913C Colonic release composition
11/28/2007CN100350912C Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid
11/28/2007CN100350911C Pharmaceutical compsn. comprising poorly water-soluble active ingredient, surfactant and water-soluble polymer
11/28/2007CN100350910C Method for preparing freeze dried cefathiamidine
11/28/2007CN100350909C Method for preparing insoluble drug single-tablet-core single-chamber osmotic pump sustained-release preparations and its product
11/28/2007CN100350906C Dichlofenas sodium slow release suppository and its preparation method
11/28/2007CN100350905C Treatment of burns
11/28/2007CN100350903C Medicaments for treating colics
11/28/2007CN100350900C Diphase capsule of compound dalbergia wood and preparation method
11/28/2007CN100350899C Diphase capsule of red sage root for coronary heart disease and preparation method
11/28/2007CN100350898C Diphase capsule of compound notoginseng and preparation method
11/28/2007CN100350897C Two-phase hard capsule and its application
11/28/2007CN100350896C Raw rhubarb powder injection and its prepn
11/27/2007US7300990 A block copolymer of the A-B or A-B-A type in which A and B are different in which at least one of the A and B is formed from ethylenically unsaturated monomer including a zwitterionic monomer; is 2-methacryloyloxyethyl-2'-trimethylammonium ethyl phosphate inner salt as a monomer; for drug delivery
11/27/2007US7300919 Pulmonary delivery of active fragments of parathyroid hormone
11/27/2007US7300673 exposing substrates to metal ions, then to basic environments to form thin films comprising antimicrobially active oxidized silver; medical equipment
11/27/2007US7300671 Method and apparatus for preparing microparticles using in-line solvent extraction
11/27/2007US7300670 Oral suspension formulation
11/27/2007US7300669 Fatty alcohol, skin conditioner, propylene glycol, mineral oil or white soft paraffin and water; fluticasone propionate and oil in water emulsion includig excipients; antiinflammatory agents
11/27/2007US7300668 System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
11/27/2007US7300667 using containing povidone iodine liposome preparations
11/27/2007US7300666 Mixture for transdermal delivery of low and high molecular weight compounds
11/27/2007US7300664 Vaginally administrable progesterone-containing tablets and method for preparing same
11/27/2007CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007CA2338896C Fast dissolving ibuprofen containing compositions having analgesic activity
11/27/2007CA2309380C Viscous compositions containing carbon dioxide
11/27/2007CA2306883C Fast-dissolving pharmaceutical composition comprising as-3201
11/27/2007CA2292600C Compositions and methods for inhibiting photoaging of skin
11/27/2007CA2271683C Coated particles, methods of making and using
11/27/2007CA2186892C Methods for treating pulmonary vasoconstriction and asthma
11/26/2007CA2580982A1 Compositions and methods for the cure of hiv/aids
11/23/2007CA2589819A1 Method for treatment of neurodegenerative disorders
11/22/2007WO2007134293A2 Wordspotting system
11/22/2007WO2007134292A2 Treprostinil administration using a metered dose inhaler
11/22/2007WO2007134288A2 Electrode-battery assembly for tens device
11/22/2007WO2007134263A2 System and method for concurrent sessions in a peer-to-peer hybrid communications network
11/22/2007WO2007134158A2 Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
11/22/2007WO2007133928A2 Marine riser and method for making
11/22/2007WO2007133807A2 Polymers for functional particles
11/22/2007WO2007133802A2 Pharmaceutical formulations of pimavanserin
11/22/2007WO2007133766A2 Electrically-pumped (ga,in, ai) n vertical-cavity surface-emitting laser
11/22/2007WO2007133758A1 Composition and improved method for preparation of small particles
11/22/2007WO2007133711A2 Pharmaceutical compositions for vein irritating drugs
11/22/2007WO2007133508A1 Water dispersible films for delivery of active agents to the epidermis
11/22/2007WO2007133382A2 Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
11/22/2007WO2007133203A1 Controlled dose drug delivery system
11/22/2007WO2007133141A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007WO2007133140A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007WO2007133082A1 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
11/22/2007WO2007133020A1 A process of preparing microspheres for sustained release having improved dispersibility and syringeability
11/22/2007WO2007132907A1 Hydrogel suspension and manufacturing process thereof
11/22/2007WO2007132873A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof
11/22/2007WO2007132853A1 Refining apparatus
11/22/2007WO2007132852A1 Poorly-water-soluble pharmaceutical agent
11/22/2007WO2007132828A1 Method of producing nanoparticle dispersion of medicinal component
11/22/2007WO2007132790A1 Liposome having lipid membrane containing bacterial cell component
11/22/2007WO2007132718A1 Solid preparation comprising adenosine 5'-triphosphate or physiologically acceptable salt thereof
11/22/2007WO2007132710A1 Bactericidal/preservative agent
11/22/2007WO2007132328A2 Novel galenic forms of artemisin and its derivatives in combination with other antimalarial agents for treating malaria
11/22/2007WO2007132296A2 Multilayer tablet
11/22/2007WO2007132134A2 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
11/22/2007WO2007132091A1 New form of administration of racecadotril
11/22/2007WO2007132022A2 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
11/22/2007WO2007131930A1 Tablet formulation comprising repaglinide and metformin
11/22/2007WO2007131812A1 Use of tannins in filters
11/22/2007WO2007131804A1 Tablet composition with a prolonged release of tamsulosin
11/22/2007WO2007131517A1 Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
11/22/2007WO2007131365A1 Treatment of neoplastic disorders using a farnesyl dibenzodiazepinone administered by continuous intravenous infusion
11/22/2007WO2007131357A1 Pharmaceutical composition having reduced abuse potential
11/22/2007WO2007131329A1 Treatment of ubiquitin-proteasome system dysfunction related disorders
11/22/2007WO2007131286A1 Nanostructures suitable for delivery of agents
11/22/2007WO2007113762A8 Bulking of soft tissue
11/22/2007WO2007112750A3 Tablets and capsules comprising immunogens for oral administration
11/22/2007WO2007112138A3 Method of using guava extract and composition including guava extract
11/22/2007WO2007109141A3 Pharmaceutical compositions for intranasal administration comprising a melatonin receptor agonist, uses thereof
11/22/2007WO2007108004A8 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
11/22/2007WO2007104173A3 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof
11/22/2007WO2007103877A3 Pharmaceutical formulations of a monohydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
11/22/2007WO2007103194A3 Aqueous moisturizers and lubricants and uses thereof
11/22/2007WO2007100524A3 Repeat sequence protein polymer nanoparticles optionally containing active agents and their preparation
11/22/2007WO2007096924A3 Extraction, preparation and use of active principles of the aloe plant for producing self-meditaion devices such as controlled-release gauzes, bandages, stockings, elastic bands and arch supports
11/22/2007WO2007090091A3 Drug delivery systems comprising weakly basic drugs and organic acids
11/22/2007WO2007087624A3 Transluminal drug delivery methods and devices
11/22/2007WO2007084468A3 Photodynamic cosmetic procedure and healing method
11/22/2007WO2007083316A3 Microspheres comprising nanocapsules containing a lipophilic drug
11/22/2007WO2007076310A3 Iontophoretic transdermal delivery of nicotine salts
11/22/2007WO2007062323A3 Machine and method for pharmaceutical and pharmaceutical-like product assembly
11/22/2007WO2007056522A3 Remote controlled in vivo reaction method
11/22/2007WO2007056176A3 Compositions for preventing and reducing delayed onset muscle soreness
11/22/2007WO2007053810A3 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, preparation, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
11/22/2007WO2007045953A3 A composite based on an apatite and an alginate, methods for its preparation and uses as bone substitute
11/22/2007WO2007035954A3 Vaginal tablets comprising misoprostol and methods of making and using the same
11/22/2007WO2007021968A3 Sustained release antihistamine and decongestant composition
11/22/2007WO2007019186A3 Method for treating skin irritations such as diaper rash and the like